Is alcohol-avoidance training effective and feasible in regular treatment?

ISRCTN ISRCTN18432640
DOI https://doi.org/10.1186/ISRCTN18432640
Submission date
18/02/2021
Registration date
22/02/2021
Last edited
22/02/2021
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English Summary

Background and study aims
An alcohol use disorder (AUD) is drinking that causes distress and harm. Alcohol-Avoidance Training (AAT) using a PC and joystick is a promising new treatment for patients with AUD, helping them to avoid relapse. However, it is not known whether AAT also works in practice in different types of clinics. The aim of this study is to find out whether AAT reduces relapse rates in currently abstinent alcohol-dependent patients in 10 German rehabilitation clinics.

Who can participate?
Alcohol-dependent inpatients who are currently abstinent and receive treatment at one of 10 German rehabilitation clinics.

What does the study involve?
Patients are randomly allocated to the active training group or the control group. In addition to usual treatment, all patients in the active training group receive six sessions of AAT. During AAT, patients use a joystick to push away pictures of alcoholic drinks and pull closer pictures of non-alcoholic drinks. Patients in the control group receive only treatment-as-usual.

What are the possible benefits and risks of participating?
The possible benefit is a reduced risk of relapse. There are no risks.

Where is the study run from?
The Salus Clinic Lindow (Germany)

When is the study starting and how long is it expected to run for?
July 2010 to January 2015

Who is funding the study?
The German Pension Fund (Deutsche Rentenversicherung Bund) (Germany)

Who is the main contact?
Prof. Dr Mike Rinck
m.rinck@psych.ru.nl

Contact information

Prof Mike Rinck
Scientific

PO Box 9104
Nijmegen
6500 HE
Netherlands

Phone +31 (0)243612154
Email m.rinck@psych.ru.nl

Study information

Study designMulticenter interventional non-blinded randomized controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typePrevention
Participant information sheet Not available in web format, please use the contact details to request a participant information sheet
Scientific titleEffectiveness and feasibility of alcohol-avoidance training: a phase 4 multi-center randomized controlled trial
Study acronymAATMC
Study hypothesisActive Alcohol-Avoidance Training reduces relapse rates in currently abstinent alcohol-dependent patients in 10 German rehabilitation clinics.
Ethics approval(s)Approved 02/02/2011, Ethics Board: Ethikkommission der Fakultaet Human- und Sozialwissenschaften der Universität Chemnitz (Ethics Committee of the Dept. of Human and Social Sciences, Chemnitz University, Technical University Chemnitz, 09107 Chemnitz, Germany; +49 (0)371-53134535;
ethik@hsw.tu-chemnitz.de), ref: 02022011
ConditionPrevention of relapse in currently abstinent patients with Alcohol Use Disorder
InterventionDuring their 3-months stay at one of the 10 participating rehabilitation clinics, currently abstinent alcohol-dependent patients are randomly assigned by coin toss to an active training group or a control group.
Active training condition: In addition to treatment-as-usual, patients complete six sessions of alcohol-avoidance training. During each session, they use a joystick and a PC to push away 100 pictures of alcoholic drinks and pull closer 100 pictures of non-alcoholic drinks.
Control condition: Treatment-as-usual only.

Total duration of follow-up: 12 months
Intervention typeBehavioural
Primary outcome measureRelapse measured using a standard questionnaire given on paper or via telephone at 3-months, 6-months, and 12-months follow-up
Secondary outcome measures1. Evaluation of the training by patients, measured using a questionnaire at the end of the training
2. Return rate recorded at each follow-up point per clinic
Overall study start date01/07/2010
Overall study end date01/01/2015

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants1400 (140 per clinic)
Total final enrolment1586
Participant inclusion criteriaAlcohol dependence, currently abstinent
Participant exclusion criteria1. Non-native speaker of German
2. History of schizophrenia or psychotic disorders
3. Visual or hand-motor handicaps
4. Strong withdrawal symptoms
5. Severe neurological disorders
Recruitment start date01/09/2012
Recruitment end date01/10/2013

Locations

Countries of recruitment

  • Germany

Study participating centres

AHG Klinik Toenisstein
Hochstraße 25
Bad Neuenahr-Ahrweiler
53474
Germany
AHG Klinik Wilhelmsheim
Wilhelmsheim 11
Oppenweiler
71570
Germany
Bernhard-Salzmann-Klinik
Buxelstraße 50
Guetersloh
33334
Germany
Fachklinik Fredeburg
Zu den Drei Buchen 1
Schmallenberg
57392
Germany
Fachkrankenhaus Hansenbarg
Franz-Barca-Weg 36
Hanstedt
21271
Germany
Fontaneklinik Motzen
Fontanestraße 5
Mittenwalde OT Motzen
15749
Germany
Paracelsus Wiehengebirgsklinik
Kokenrottstraße 71
Bad Essen
49152
Germany
Salus Klinik Friedrichsdorf
Landgrafenplatz 1
Friedrichsdorf
61381
Germany
salus klinik Huerth
Willy-Brandt-Platz 1
Huerth
50354
Germany

Sponsor information

Radboud University Nijmegen
University/education

Behavioural Science Institute
PO Box 9104
Nijmegen
6500 HE
Netherlands

Phone +31 (0)24 3610082
Email secr@bsi.ru.nl
Website http://www.ru.nl/english/
ROR logo "ROR" https://ror.org/016xsfp80

Funders

Funder type

Other

German Pension Fund (Deutsche Rentenversicherung Bund)

No information available

Results and Publications

Intention to publish date01/01/2022
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planPlanned publication in a high-impact peer-reviewed journal. No additional documents are available.
IPD sharing planAnonymized participant-level data will be available upon request from Mike Rinck (m.rinck@psych.ru.nl).

Editorial Notes

22/02/2021: Trial's existence confirmed by Ethics Board: Ethikkommission der Fakultaet Human- und Sozialwissenschaften der Universität Chemnitz.